Suki, a healthcare startup specializing in AI voice assistants for medical providers, has secured $70 million in Series D funding, raising its total funding to $165 million at a valuation of approximately $500 million. The investment comes amid growing demand for AI solutions in healthcare. Meanwhile, Scope3, which develops tools to monitor the carbon footprint of digital advertising, has raised $25 million led by GV. This funding will enable Scope3 to expand its offerings to include tools that track the climate impact of AI technologies. Additionally, Abridge, another AI-focused healthcare company that transcribes doctor-patient conversations, has raised $250 million at a pre-money valuation of $2.5 billion, reflecting a significant interest in AI applications within the medical field.